Private investors: FCPI

Investing in innovative SMEs, supporting growth and employment

Channel individual savings into innovative start-ups

  • FCPI (funds dedicated to innovative companies) are funds approved by the AMF that allow individual investors to invest in up-and-coming and innovative unlisted companies.
  • This asset class presents liquidity and loss of capital risks

Invest in technology and life sciences

  • Omnes Capital Venture Capital team manages €700 million in assets under management. For over 20 years, it has successfully supported dynamic and innovative companies in the digital and health sectors.

Benefit from tax incentives

  • Reduces your income tax by an amount equivalent to 18% of your investment (excl. entry charges) up to €2,160 for a single individual (for a maximum investment excl. entry charges of €12,000) or up to €4,320 for a married couple (for an investment of €24,000 excl. entry charges).
    For an investment of €10,000, the incentive works out at 10,000 x 18%, i.e. €1,800
  • In return for blocking assets over a period of 8 years, extendable by 1 year by decision of the management company
FCPI managed by Omnes Capital

Net asset values of Omnes Capital FCPI
> Download the document (French only)

 

The performance of a private equity fund is appreciated over a long investment period. The Net Asset Value may not reflect the potential of the portfolio assets over the life of the Fund and may not reflect the potential evolution of their fair value.

Key figures
20
years’
experience
€700
million
in assets under management
21
FCPI under management
24,000
clients
NewsRoom
Press release
09 April 2019
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Appointments within Omnes: Omnes welcomes five newcomers as Director, Principal, Analyst, Middle Office Managers, and promotes four Principals
Press release
03 April 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
AgomAb Therapeutics Completes Euros 21m Series A Financing
Press release
19 March 2019
Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy

Omnes announces a 15% investor net IRR on its Capenergie 2 fund, focused on renewable energy
Publication
Omnes Newsletter no 32: mid cap news H2 2017
Press release
13 March 2019
Therapixel secures a €5 million Series A financing and strengthens its governance
Therapixel secures a €5 million Series A financing and strengthens its governance
Press release
28 January 2019
FEIH, co-owned by ENGIE and Crédit Agricole Assurances, reaches 1.5 GW of solar and wind capacity
FEIH, co-owned by ENGIE and Crédit Agricole Assurances, reaches 1.5 GW of solar and wind capacity
Press release
24 January 2019
Teach on Mars completes €7M funding round to finance the next-phase deployment of its mobile learning technology
Teach on Mars completes €7M funding round to finance the next-phase deployment of its mobile learning technology

Pages